Skip to main content
. 2020 Nov 19;13(11):405. doi: 10.3390/ph13110405

Table 1.

MIC and MBC values for carvacrol (parent compound) and its semi-synthetic derivatives (146) against nine strains of H. pylori. Antibiotic susceptibility is reported for each H. pylori strain.

H. pylori Strains
MIC/MBC (µg/mL)
F4 190 23 110 R NCTC 11637 F1 F34/497 F40/499 F40/442
Carvacrol 64/64 64/64 64/64 64/64 64/64 64/64 16/32 32/64 32/64
1 128/128 >128/>128 >128/>128 128/128 >128/>128 128/128 128/128 64/64 64/64
2 64/64 64/128 >128/>128 64/64 128/>128 64/64 32/64 32/64 64/64
3 64/128 64/64 128/>128 64/64 64/64 64/64 32/64 64/64 64/64
4 128/128 128/128 128/128 128/128 128/128 128/128 128/128 128/128 128/128
5 64/64 64/64 64/64 64/64 128/128 64/64 64/64 64/64 64/64
6 16/32 32/32 32/64 64/128 64/64 32/32 32/32 16/16 32/32
7 32/32 32/64 64/128 64/128 64/64 32/32 32/32 64/64 64/64
8 64/64 64/64 64/64 64/128 64/64 64/64 64/64 64/64 64/64
9 8/8 32/32 32/64 32/32 32/32 16/16 8/8 16/16 16/16
10 128/128 128/128 128/128 128/128 128/128 128/128 128/128 128/128 128/128
11 128/128 128/128 128/128 128/128 128/128 128/128 128/128 128/128 128/128
12 64/64 32/32 128/128 64/64 64/64 64/64 64/64 32/64 64/64
13 >128/>128 >128/>128 >128/>128 >128/>128 >128/>128 >128/>128 128/128 128/128 128/128
14 64/64 64/64 64/64 64/64 64/64 64/64 64/64 64/64 64/64
15 64/128 64/64 32/32 64/64 64/64 32/64 32/32 32/32 32/32
16 8/16 8/16 32/32 8/8 32/32 4/8 2/2 8/8 4/8
17 32/32 32/32 16/16 32/32 32/32 16/16 8/32 16/16 16/16
18 32/32 32/64 32/32 64/128 32/64 16/32 16/16 16/16 16/16
19 32/64 >128/>128 >128/>128 >128/>128 128/128 32/32 16/32 64/128 64/128
20 16/32 128/128 32/64 128/>128 64/64 32/32 16/32 64/64 64/64
21 16/32 32/32 32/64 32/64 32/64 32/32 16/32 32/32 32/32
22 >128/>128 >128/>128 >128/>128 >128/>128 >128/>128 128/>128 >128/>128 >128/>128 >128/>128
23 64/64 32/32 64/64 32/64 64/64 64/64 64/64 32/32 32/64
24 32/32 64/128 32/32 64/64 64/128 32/32 128/128 32/32 32/32
25 64/64 32/32 64/64 64/64 64/64 64/64 32/64 32/64 32/64
26 32/32 32/32 32/32 32/32 32/64 16/16 32/64 16/16 16/16
27 32/64 32/32 64/64 32/32 64/64 32/64 32/32 32/32 32/32
28 16/16 16/16 32/64 16/32 16/32 8/8 32/64 8/8 8/16
29 16/64 32/64 64/64 64/64 64/64 64/64 16/32 64/64 16/32
30 32/64 64/128 64/128 64/128 64/128 64/64 32/32 32/64 32/64
31 32/32 16/32 32/64 16/16 64/64 16/32 64/64 8/16 16/32
32 16/32 64/64 64/64 64/64 32/64 32/32 16/16 32/64 16/32
33 8/8 4/4 8/8 4/4 4/4 8/8 8/8 8/8 8/8
34 8/8 4/4 4/4 4/8 4/4 4/4 4/4 4/4 4/4
35 4/8 16/16 32/64 16/16 32/64 4/4 2/2 16/16 16/16
36 8/16 4/4 8/8 8/8 8/8 8/8 8/8 8/8 8/8
37 32/64 64/64 64/64 64/64 64/64 32/64 32/32 64/64 32/64
38 8/8 4/4 8/8 4/4 8/8 4/4 2/2 8/8 8/8
39 2/2 4/4 2/2 4/4 2/2 2/2 2/2 2/2 2/2
40 8/8 8/16 8/16 8/16 8/16 4/4 4/4 4/4 4/4
41 >128/>128 >128/>128 >128/>128 >128/>128 >128/>128 >128/>128 >128/>128 >128/>128 >128/>128
42 16/16 16/32 32/32 32/32 32/32 32/32 16/32 32/32 16/16
43 32/32 64/128 128/>128 128/>128 128/>128 32/32 64/128 32/32 32/32
44 32/32 32/32 32/32 32/32 32/32 32/32 32/32 32/32 32/32
45 32/32 32/128 64/>128 32/128 64/128 32/32 32/32 32/32 32/32
46 64/128 32/64 32/64 32/64 32/64 64/128 64/>128 32/64 64/128
Antibiotic susceptibility MTZ+ MTZ− MTZ− MTZ+ MTZ+ MTZ− MTZ+ MTZ+ MTZ+
CLR+ CLR− CLR− CLR− CLR− CLR+ CLR+ CLR+ CLR−
AMX− AMX− AMX− AMX− AMX− AMX− AMX− AMX− AMX−

MTZ+ = metronidazole resistant (MIC > 8 µg/mL); MTZ− = metronidazole susceptible (MIC ≤ 8 µg/mL); CLR+ = clarithromycin resistant (MIC > 0.25 µg/mL); CLR− = clarithromycin susceptible (MIC ≤ 0.25 µg/mL); AMX+ = amoxicillin resistant (MIC > 0.125 µg/mL); AMX− = amoxicillin susceptible (MIC ≤ 0.125 µg/mL). Compounds selected for in vitro anti-proliferative activity assays against AGS cells are highlighted in grey.